Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXAE1I
|
||||
| Drug Name |
(S)-1-[(2S,4R)-4-(6-Methoxy-benzo[b]thiophen-2-yl)-2-methyl-piperidin-1-yl]-3-(2-methyl-1H-indol-4-yloxy)-propan-2-ol
|
||||
| Synonyms |
CHEMBL339086
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C27H32N2O3S
|
||||
| Canonical SMILES |
COc1ccc2cc(sc2c1)[C@@H]3CCN(C[C@H](O)COc4cccc5[nH]c(C)cc45)[C@@H](C)C3
|
||||
| InChI |
InChI=1S/C27H32N2O3S/c1-17-11-23-24(28-17)5-4-6-25(23)32-16-21(30)15-29-10-9-20(12-18(29)2)26-13-19-7-8-22(31-3)14-27(19)33-26/h4-8,11,13-14,18,20-21,28,30H,9-10,12,15-16H2,1-3H3/t18-,20+,21-/m0/s1
|
||||
| InChIKey |
OVGLJCMSYVKXAS-TYPHKJRUSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.